Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Worm-Like Nanoparticles Used to Kill Breast Cancer Cells

By BiotechDaily International staff writers
Posted on 26 Dec 2013
Image: Microscope images of the worm-like, rod-like, micelle- and vesicle-shaped nanoparticles (Photo courtesy of University of New South Wales, Australia).
Image: Microscope images of the worm-like, rod-like, micelle- and vesicle-shaped nanoparticles (Photo courtesy of University of New South Wales, Australia).
Cylinder-shaped nanoparticles have been shown to be seven times more lethal than traditional spherical ones when delivering drugs to breast cancer cells, an international team of researchers has discovered.

Moreover, the worm-shaped drug delivery vehicles are not anymore toxic to healthy cells according to the study, which was published December 2013 in the journal Polymer Chemistry. In this study, different polymeric nanoparticle shapes (including spherical micelle, cylindrical micelle, and vesicles) were examined, and the early findings suggest shape plays an important role in the cell uptake and toxicity response. The project was co-led by Assoc. Prof. Cyrille Boyer, from the University of New South Wales (UNSW) School of Chemical Engineering (Sydney, Australia) and the Australian Center for NanoMedicine (Sydney), and Prof. Thomas Davis from Monash University (Melbourne, Australia), and involved Dr. Bunyamin Karagoz from Istanbul Technical University (Turkey).

Developing nanoparticles to target drugs directly to specific regions of the body is an increasing field of medicine, and these new findings suggest changing the shape of nanoparticles could slash both treatment costs and side effects. “What we’ve discovered is that a different shaped nanoparticle can have a very different effect on cancer cells, even with the same amount of drug,” said Dr. Boyer. “However there is still a lot of work to do and we need to test the nanoparticles in vitro with a range of cancer cells.”

Research had earlier mostly focused on spherical drug delivery systems as they are easier to make, but this new study additionally offers a simple and inexpensive approach to devising three different nanoparticle shapes: vesicular, spherical, and tubular or “worm-like.”

The researchers are now looking into whether cylindrical shape nanoparticles also deliver drugs more effectively to other types of cancers.

Related Links:

University of New South Wales School of Chemical Engineering
Monash University
Istanbul Technical University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent treated with the HDL peptide (right). Note the much narrowed lung artery, and thick walls and larger chamber of the heart in the diseased animal and improvements with 4F peptide treatment (Photo courtesy of UCLA - University of California, Los Angeles).

Apolipoprotein A-1 Mimetic Peptide Reverses Pulmonary Hypertension in Rodent Models

A small peptide that mimics the activity of apolipoprotein A-1 (apo A-1), the main protein component of the high density lipoproteins (HDL), counteracted the effects of oxidized lipids and alleviated symptoms... Read more

Drug Discovery

view channel
Image: (Left) Neurons in brains from people with autism do not undergo normal pruning during childhood and adolescence. The images show representative neurons from unaffected brains (left) and brains from autistic patients (right); the spines on the neurons indicate the location of synapses (Photo courtesy of Guomei Tang, PhD and Mark S. Sonders, PhD, Columbia University Medical Center).

Autistic Youngsters Found to Have Too Many Brain Synapses

Autistic children and adolescents have been shown to have an excess of brain synapses, and this is due to a slowdown in the normal brain “trimming” process during development, according to new findings.... Read more

Lab Technologies

view channel

Important Immune Cell Regulators’ Response Identified

A new strategy could help accelerate laboratory research and the development of potential therapeutics, including vaccines. The technology may also be used to identify the genes that underlie tumor cell development. There are approximately 40,000 genes in each of the body’s cells, but functions for only approximately... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.